Single User License
INR 8330
Site License
INR 16660
Corporate User License
INR 24990

Service Tax Additional

select a format

Single User License
USD 125
Site License
USD 250
Corporate User License
USD 375


Request a quote
Request a Customized research
Request for Sample Report

Recent Viewed Reports

Why Ken Reasearch?


While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"

Ken Research completed the report successfully with tough deadline and large requirement. Really appreciate it... "Sales Manager, Largest India Aesthetic Laser Manufacturer"

We found the report really useful in understanding the complex Indian market and it provided lots of high quality insights. On the basis of this we commissioned Ken to produce a bespoke follow up to answer some specific questions about our market. This is now being used to help develop our marketing and sales strategy. We were very pleased with the comprehensive coverage, detail provided and actionable insights.... "Owner, Therefore Consulting UK"

Lincoln Pharmaceuticals Ltd (LINCOLN)-Financial and Strategic SWOT Analysis Review

Lincoln Pharmaceuticals Ltd (LINCOLN)-Financial and Strategic SWOT Analysis Review

  • Products Id :- GDPH83116FSA
  • |
  • Pages: 35
  • |
  • September 2016
  • |
  • |
  Request for Sample Report

Executive Summary

Lincoln Pharmaceuticals Ltd (LINCOLN)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

Business description-A detailed description of the company's operations and business divisions.

Corporate strategy-Analyst's summarization of the company's business strategy.

SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

Company history-Progression of key events associated with the company.

Major products and services-A list of major products, services and brands of the company.

Key competitors-A list of key competitors to the company.

Key employees-A list of the key executives of the company.

Executive biographies-A brief summary of the executives' employment history.

Key operational heads-A list of personnel heading key departments/functions.

Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

Key manufacturing facilities-A list of key manufacturing facilities of the company.

Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.


Lincoln Pharmaceuticals Ltd (Lincoln Pharmaceuticals) manufactures markets and exports pharmaceutical products. The company provides pharmaceuticals in anti cold, anti biotic, otolaryngology and pain management therapy areas. It also offers anti malarial drugs and a complete portfolio range of gynecology medications. Lincoln Pharmaceuticals produces pharmaceuticals in capsules, tablets, injections, liquid and dry syrups (dry powder) forms. The company operates manufacturing facilities in Khatraj and Ahmedabad. It also operates a research and development center. The company markets its products in the domestic market and international markets including East and West Africa, South East Asia and Latin and Central America. Lincoln Pharmaceuticals is headquartered in Ahmedabad, Gujarat, India.

Lincoln Pharmaceuticals Ltd Key Recent Developments

Aug 11, 2016: Lincoln Pharmaceuticals Announces Financial Results for the Quarter ended on 30 June, 2016

Jan 18, 2016: Lincoln Pharmaceuticals: Chloramphenicol Sodium Succinate Injection banned

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Section 1-About the Company 6

Lincoln Pharmaceuticals Ltd-Key Facts 6

Lincoln Pharmaceuticals Ltd-Key Employees 7

Lincoln Pharmaceuticals Ltd-Key Employee Biographies 8

Lincoln Pharmaceuticals Ltd-Major Products and Services 9

Lincoln Pharmaceuticals Ltd-History 11

Lincoln Pharmaceuticals Ltd-Company Statement 12

Lincoln Pharmaceuticals Ltd-Locations And Subsidiaries 13

Head Office 13

Other Locations & Subsidiaries 13

Section 2-Company Analysis 14

Lincoln Pharmaceuticals Ltd-Business Description 14

Lincoln Pharmaceuticals Ltd-Corporate Strategy 15

Lincoln Pharmaceuticals Ltd-SWOT Analysis 16

SWOT Analysis-Overview 16

Lincoln Pharmaceuticals Ltd-Strengths 16

Strength-Focus on Research and Development Activities 16

Strength-Improved Financial Position 16

Strength-Leading Pharmaceutical Company 16

Lincoln Pharmaceuticals Ltd-Weaknesses 17

Weakness-Registration Cancellation in Tanzania 17

Lincoln Pharmaceuticals Ltd-Opportunities 18

Opportunity-Changing Demographics 18

Opportunity-Product Innovation 18

Opportunity-Quality Commitment 18

Lincoln Pharmaceuticals Ltd-Threats 19

Threat-Product Liability Claims 19

Threat-Competitive Landscape 19

Threat-Stringent Government Regulations 19

Lincoln Pharmaceuticals Ltd-Key Competitors 20

Section 3-Company Financial Ratios 21

Financial Ratios-Capital Market Ratios 21

Financial Ratios-Annual Ratios 22

Performance Chart 23

Financial Performance 23

Financial Ratios-Interim Ratios 24

Financial Ratios-Ratio Charts 25

Section 4-Company's Lifesciences Financial Deals and Alliances 26

Lincoln Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 26

Lincoln Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016 27

Lincoln Pharmaceuticals Ltd, Recent Deals Summary 28

Section 5-Company's Recent Developments 29

Aug 11, 2016: Lincoln Pharmaceuticals Announces Financial Results for the Quarter ended on 30 June, 2016 29

Jan 18, 2016: Lincoln Pharmaceuticals: Chloramphenicol Sodium Succinate Injection banned 30

Section 6-Appendix 31

Methodology 31

Ratio Definitions 31

About GlobalData 35

Contact Us 35

Disclaimer 35

List of Figures

Lincoln Pharmaceuticals Ltd, Performance Chart (2012-2016) 23

Lincoln Pharmaceuticals Ltd, Ratio Charts 25

Lincoln Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 26

Lincoln Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 27

List of Tables

Lincoln Pharmaceuticals Ltd, Key Facts 6

Lincoln Pharmaceuticals Ltd, Key Employees 7

Lincoln Pharmaceuticals Ltd, Key Employee Biographies 8

Lincoln Pharmaceuticals Ltd, Major Products and Services 9

Lincoln Pharmaceuticals Ltd, History 11

Lincoln Pharmaceuticals Ltd, Subsidiaries 13

Lincoln Pharmaceuticals Ltd, Key Competitors 20

Lincoln Pharmaceuticals Ltd, Ratios based on current share price 21

Lincoln Pharmaceuticals Ltd, Annual Ratios 22

Lincoln Pharmaceuticals Ltd, Interim Ratios 24

Lincoln Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 26

Lincoln Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016 27

Lincoln Pharmaceuticals Ltd, Recent Deals Summary 28

Currency Codes 31

Capital Market Ratios 31

Equity Ratios 32

Profitability Ratios 32

Cost Ratios 33

Liquidity Ratios 33

Leverage Ratios 34

Efficiency Ratios 34

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@]

Torrent Pharmaceuticals Limited

Sun Pharmaceutical Industries Limited

Elder Pharmaceuticals Ltd.

Dishman Pharmaceuticals and Chemicals Limited

Amrutanjan Health Care Ltd.

Abbott India Limited

Lincoln Pharmaceuticals Ltd, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts

Related Products in vertical
Other reports by publisher
Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204


Company Brochure

Engage with Us

query [@]